WuXi PharmaTech (WX) Tops Q4 EPS by 2c, FY Guidance Falls Short

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. QCOM
7. DDOG
8. EW
9. ZG
10. W

Go back to WuXi PharmaTech (WX) Tops Q4 EPS by 2c, FY Guidance Falls Short

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results

March 5, 2015 4:30 PM EST

SHANGHAI, March 5, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the fourth quarter and full year of 2014. 

Fourth-Quarter 2014 Highlights

Net Revenues Increased 21.3% Year Over Year to $190.6 Million Laboratory Services Net Revenues Grew 17.7% Year Over Year to $140.5 Million Manufacturing Services Net Revenues Increased 32.8% Year Over Year to $50.1 Million GAAP Diluted Earnings Per... More